Fuchs heterochromic iridocyclitis

Uvea

Key Points

•Stellate KPs scattered diffusely over the entire endothelium (not confined to Arlt's triangle) with absence of posterior synechiae are the hallmark features of FHI
•FHI is one of the few forms of uveitis where posterior synechiae do NOT form — if synechiae are present, reconsider the diagnosis
•Rubella virus is the most strongly implicated aetiology — aqueous PCR positive in ~50–70%; GWC >3 for rubella antibodies is significant
•Overtreatment with corticosteroids is the most common management error — the low-grade inflammation rarely needs aggressive anti-inflammatory therapy
•Cataract surgery outcomes are the best among all uveitic cataracts (~90% achieve VA ≥6/12); glaucoma (15–25%) is the main threat to permanent vision loss

1. Definition

A chronic, low-grade, typically unilateral anterior uveitis characterised by iris heterochromia, diffuse stellate keratic precipitates, absence of posterior synechiae, and frequent development of cataract and secondary glaucoma. It accounts for approximately 2–5% of all uveitis cases. Also known as Fuchs uveitis syndrome (FUS).

2. Epidemiology

Accounts for 2–5% of all uveitis referrals (Nussenblatt & Whitcup, 4th Ed). No racial or geographic predilection, though heterochromia is more easily detected in light-eyed individuals. Equal sex distribution. Typically presents in the third to fourth decade (20–40 years). Usually unilateral (90%); bilateral cases (~10%) may lack obvious heterochromia. Often diagnosed late due to its indolent, minimally symptomatic nature — many patients present only when cataract-related visual decline occurs.

3. Aetiology and causes

Aetiology remains debated. Rubella virus is strongly implicated based on:

Detection of rubella virus RNA by PCR in aqueous humour
Elevated Goldmann-Witmer coefficient for rubella-specific antibodies in aqueous vs serum
Reduced incidence of FHI in populations with high rubella vaccination rates

Other proposed associations include ocular toxoplasmosis (especially in Brazil), CMV infection (especially in Asian populations), HSV, and sympathetic denervation (Horner syndrome model). The condition likely represents a final common pathway of chronic low-grade anterior segment inflammation from multiple possible triggers.

4. Pathogenesis

Chronic viral infection (rubella) in the iris and ciliary body causes a persistent low-grade immune response. Plasma cells and lymphocytes (predominantly CD8+ T cells) infiltrate the iris stroma. Progressive iris stromal atrophy leads to loss of stromal pigment and heterochromia (the affected eye becomes lighter in dark-eyed individuals, or relatively darker in light-eyed individuals — inverse heterochromia). Chronic inflammation disrupts the blood-aqueous barrier, allowing protein and cells to leak continuously. Rubella-induced damage to the trabecular meshwork endothelium contributes to secondary open-angle glaucoma. Lens epithelial damage from chronic low-grade inflammation leads to posterior subcapsular cataract.

5. Classification

Not formally classified by staging systems, but clinical variants include:

Classic FHI — unilateral, heterochromia, stellate KPs, cataract
FHI without heterochromia — bilateral or dark-eyed patients where heterochromia is not clinically apparent
FHI with vitritis — ~20% have mild vitreous cells/opacities
Rubella-associated FHI — PCR/GWC confirmed rubella
Non-rubella FHI — associated with CMV, toxoplasmosis, or idiopathic

SUN classification: chronic anterior uveitis, insidious onset, persistent course.

6. Risk factors and associations

Lack of rubella vaccination (congenital or postnatal rubella infection).
Light iris colour (heterochromia more clinically apparent).
No HLA associations established.
No familial pattern.
Concurrent ocular toxoplasmosis (in ~10% of FHI cases, particularly in endemic areas).
CMV seropositivity (Asian populations).
There is no association with systemic autoimmune disease — this distinguishes FHI from most other forms of uveitis.

7. Clinical features

Symptoms: often asymptomatic or mild blurring due to cataract or floaters. Typically discovered incidentally during routine examination or cataract evaluation. Pain, redness, and photophobia are characteristically absent or minimal.

Signs:

Heterochromia iridis (affected eye is lighter in brown-eyed individuals; may be inverse in blue-eyed individuals)
Diffuse, small, round or stellate KPs scattered over the entire endothelium (not confined to Arlt's triangle) — pathognomonic distribution
Mild anterior chamber cells (rarely >1+) with mild flare
Absence of posterior synechiae (critical distinguishing feature)
Iris stromal atrophy with loss of crypts and moth-eaten appearance
Koeppe nodules at pupillary margin (occasional)
Amsler sign: fine filiform haemorrhage from iris root vessels during paracentesis or after anterior chamber tap
Posterior subcapsular cataract (~70–80% of cases)
Vitreous cells and opacities (~20%)
Normal or elevated IOP
Fundus usually normal; rarely chorioretinal scars (if concurrent toxoplasmosis)

8. Investigations

Ophthalmic examination:

Slit-lamp: characteristic KP distribution, heterochromia assessment, synechiae check
Gonioscopy: fine neovascularisation of the angle (common but usually does not cause NVG), open angle
IOP measurement (baseline and follow-up — glaucoma screening)
Dilated fundus exam (rule out chorioretinal lesions)

Laboratory (usually a clinical diagnosis):

Aqueous humour PCR for rubella virus RNA (positive in ~50–70%)
Goldmann-Witmer coefficient for rubella antibodies (>3 is significant)
Aqueous PCR for CMV, HSV, toxoplasma (to exclude other causes)
No systemic workup typically needed as FHI has no systemic associations

Imaging: OCT if CME suspected (rare). UBM not routinely needed.

9. Differential diagnosis

Posner-Schlossman syndrome (glaucomatocyclitic crisis) — recurrent episodes of elevated IOP with mild AC reaction, no heterochromia, no cataract; CMV association
Herpetic anterior uveitis (HSV/VZV) — sectoral iris atrophy (not diffuse), elevated IOP, decreased corneal sensation, posterior synechiae may form
HLA-B27 anterior uveitis — acute, painful, fibrin, posterior synechiae form readily
Sarcoid anterior uveitis — mutton-fat KPs in Arlt's triangle, iris nodules, posterior synechiae, bilateral
Chronic idiopathic anterior uveitis — posterior synechiae common, KPs in Arlt's triangle
Iris melanoma — unilateral heterochromia from pigmented mass, no KPs

10. Complications

Cataract: posterior subcapsular cataract develops in ~70–80% of patients; most common reason for visual decline.

Secondary open-angle glaucoma: occurs in 15–25%; often refractory to medical therapy and may require surgery (main cause of permanent vision loss).

Vitreous opacities: mild in ~20%, rarely visually significant.

CME: rare (<5%).

Cataract surgery complications: increased risk of postoperative hyphema from fragile iris vessels (Amsler sign correlate) but overall good surgical outcomes.

Glaucoma is the main cause of permanent vision loss.

11. Management

General principle: FHI is a benign, chronic condition that does NOT respond well to aggressive anti-inflammatory therapy. Overtreatment with corticosteroids is a common pitfall.

Anti-inflammatory therapy:

Topical corticosteroids are generally NOT indicated for routine maintenance (low-grade inflammation is self-limited and non-damaging)
Short course of mild topical steroids (fluorometholone 0.1% or loteprednol 0.5% QID × 2–4 weeks) only if significant symptomatic flare
Cycloplegics not routinely needed (no synechiae risk)
Systemic immunosuppression is NOT indicated

Cataract management:

Phacoemulsification with IOL implantation (excellent outcomes in FHI — ~90% achieve VA ≥6/12)
In-the-bag hydrophobic acrylic PCIOL preferred
Perioperative topical steroids for 4–6 weeks
Expect mild postoperative hyphema (from fragile iris vessels) — usually self-resolving

Glaucoma management:

Topical anti-glaucoma medications (avoid prostaglandin analogues if inflammation active)
Trabeculectomy with mitomycin C or glaucoma drainage device if medical therapy fails
Avoid pilocarpine (causes miosis and increases inflammation)

12. Prognosis

Generally good visual prognosis. Most patients maintain useful vision long-term. Cataract surgery outcomes are excellent with >90% achieving VA ≥6/12 postoperatively. Glaucoma is the main threat to vision and may be difficult to control medically — ~15–25% require surgical intervention. Unlike most forms of uveitis, FHI does not cause macular complications or severe vision loss from inflammation itself. The condition does not burn out — low-grade inflammation persists indefinitely but is typically non-destructive.

Clinical Pearls

FHI is one of the few forms of uveitis where posterior synechiae do NOT form — if synechiae are present, reconsider the diagnosis.

The KPs in FHI are scattered diffusely over the entire endothelium (not limited to Arlt's triangle) and have a characteristic small, round, or stellate appearance.

Overtreatment with corticosteroids is the most common management error in FHI — the low-grade inflammation rarely needs aggressive anti-inflammatory therapy.

Amsler sign (filiform haemorrhage from iris vessels during AC tap) is characteristic and reflects fragile angle neovascularisation secondary to chronic low-grade inflammation.

In endemic areas, always check for concurrent toxoplasmic chorioretinal scars — the FHI-toxoplasmosis association is well-documented, especially in South America.

Heterochromia may be inverse in blue-eyed individuals (affected eye appears darker) — do not rely on the affected eye being lighter in all patients.

Exam trap — Fuchs heterochromic iridocyclitis (FHI) features: Unilateral, chronic low-grade anterior uveitis, NO posterior synechiae (despite chronic inflammation — unique), heterochromia (affected iris is lighter in dark-eyed patients, may be darker in light-eyed patients — inverse heterochromia), diffuse fine stellate KPs (not mutton-fat), iris stromal atrophy, and cataract (70–90%). Patients are often asymptomatic until cataract causes visual symptoms.

Exam trap — Amsler sign: During AC paracentesis or surgery in FHI, filamentous hemorrhage occurs from fragile iris vessels (Amsler sign). These abnormal angle vessels can also cause spontaneous hyphema. Despite chronic uveitis, FHI does NOT develop posterior synechiae — this is a KEY differentiator from other forms of chronic anterior uveitis.

Exam trap — FHI does NOT need aggressive treatment: Unlike most chronic uveitis, FHI has a benign inflammatory course that does NOT respond well to steroids and does NOT need immunosuppression. Do NOT treat with chronic topical or systemic steroids — the inflammation is self-limiting and low-grade. Manage the complications (cataract surgery, glaucoma treatment) rather than the inflammation.

Oral-exam questions

What is the Amsler sign? — Fine filiform haemorrhage from iris root vessels during paracentesis or AC tap. It is characteristic of FHI and reflects fragile neovascularisation from chronic low-grade ischaemia.
Why do posterior synechiae NOT form in FHI? — The inflammation is too low-grade to produce enough fibrin for adhesion between iris and lens. If synechiae are present, the diagnosis of FHI should be questioned.
What is the most common cause of permanent vision loss in FHI? — Secondary open-angle glaucoma (15–25% of cases) — it is often refractory to medical therapy and may require filtering surgery.
What viral aetiology is most strongly associated with FHI? — Rubella virus — aqueous PCR positive in ~50–70%; supported by elevated Goldmann-Witmer coefficient >3 for rubella antibodies.
Why should aggressive corticosteroid therapy be avoided in FHI? — FHI is a benign, chronic condition where the low-grade inflammation is typically non-destructive. Corticosteroids accelerate cataract and glaucoma without significantly controlling the underlying inflammation.
What is inverse heterochromia in FHI? — In light-eyed (blue/green) individuals, the affected eye may appear darker than the fellow eye due to loss of stromal architecture making the pigment epithelium more visible.
What is the association between FHI and rubella virus? — Recent evidence strongly links FHI to chronic intraocular rubella virus infection. Studies have found rubella-specific antibodies in the aqueous humor (Goldmann-Witmer coefficient positive) and rubella virus RNA in aqueous samples of FHI patients. This may explain the unilateral nature and the characteristic low-grade inflammation. FHI has become rarer in countries with widespread rubella vaccination.

Mnemonics

FUCHS

F — Fine stellate KPs (diffuse) U — Unilateral (90%) C — Cataract (PSC, 70–80%) H — Heterochromia iridis S — Synechiae ABSENT

Amsler sign

A — Anterior chamber tap → filiform haemorrhage M — Micro-vessels (neovascularisation of iris/angle) S — Sign of fragile iris vessels L — Low-grade chronic ischaemia E — Expect mild hyphema post-cataract surgery R — Rubella-associated vascular damage

Comparison Tables

FHI vs Other Causes of Heterochromia

FHI vs Other Causes of Heterochromia
Feature	Fuchs (FHI)	Horner Syndrome	Iris Melanoma	Congenital Heterochromia
Mechanism	Iris stromal atrophy from chronic inflammation	Sympathetic denervation → melanocyte hypopigmentation	Pigmented tumour mass	Developmental variation
Affected eye colour	Lighter (dark-eyed) or inverse (light-eyed)	Lighter (less melanin)	Darker (excess pigment)	Variable
KPs	Stellate, diffuse	Absent	Absent	Absent
AC cells	Mild chronic	Absent	Absent	Absent
Pupil	Normal	Miosis (affected)	Normal or distorted	Normal
Associated findings	Cataract, glaucoma	Ptosis, miosis, anhidrosis	Elevated lesion, sentinel vessels	None

Mechanism

Fuchs (FHI): Iris stromal atrophy from chronic inflammation
Horner Syndrome: Sympathetic denervation → melanocyte hypopigmentation
Iris Melanoma: Pigmented tumour mass
Congenital Heterochromia: Developmental variation

Affected eye colour

Fuchs (FHI): Lighter (dark-eyed) or inverse (light-eyed)
Horner Syndrome: Lighter (less melanin)
Iris Melanoma: Darker (excess pigment)
Congenital Heterochromia: Variable

KPs

Fuchs (FHI): Stellate, diffuse
Horner Syndrome: Absent
Iris Melanoma: Absent
Congenital Heterochromia: Absent

AC cells

Fuchs (FHI): Mild chronic
Horner Syndrome: Absent
Iris Melanoma: Absent
Congenital Heterochromia: Absent

Pupil

Fuchs (FHI): Normal
Horner Syndrome: Miosis (affected)
Iris Melanoma: Normal or distorted
Congenital Heterochromia: Normal

Associated findings

Fuchs (FHI): Cataract, glaucoma
Horner Syndrome: Ptosis, miosis, anhidrosis
Iris Melanoma: Elevated lesion, sentinel vessels
Congenital Heterochromia: None

FHI vs Posner-Schlossman Syndrome

FHI vs Posner-Schlossman Syndrome
Feature	Fuchs (FHI)	Posner-Schlossman (PSS)
Course	Chronic, persistent	Episodic, self-limited
IOP	Normal or mildly elevated	Markedly elevated (40–60 mmHg)
KPs	Stellate, diffuse	Few, small, round
Heterochromia	Present	Absent
Cataract	Common (70–80%)	Uncommon
Viral association	Rubella	CMV
Synechiae	Never	Never

Course

Fuchs (FHI): Chronic, persistent
Posner-Schlossman (PSS): Episodic, self-limited

IOP

Fuchs (FHI): Normal or mildly elevated
Posner-Schlossman (PSS): Markedly elevated (40–60 mmHg)

KPs

Fuchs (FHI): Stellate, diffuse
Posner-Schlossman (PSS): Few, small, round

Heterochromia

Fuchs (FHI): Present
Posner-Schlossman (PSS): Absent

Cataract

Fuchs (FHI): Common (70–80%)
Posner-Schlossman (PSS): Uncommon

Viral association

Fuchs (FHI): Rubella
Posner-Schlossman (PSS): CMV

Synechiae

Fuchs (FHI): Never
Posner-Schlossman (PSS): Never

KP Distribution Patterns in Anterior Uveitis

KP Distribution Patterns in Anterior Uveitis
Type	KP Morphology	Distribution	Example Conditions
Non-granulomatous (fine)	Small, round, white	Arlt's triangle (inferior cornea)	HLA-B27, idiopathic AAU
Granulomatous (mutton-fat)	Large, greasy, yellow-brown	Arlt's triangle	Sarcoidosis, TB, VKH
Stellate (FHI-type)	Small, stellate/round	Diffuse — entire endothelium	Fuchs heterochromic iridocyclitis
Coin-shaped	Medium, round, flat	Central/paracentral	HSV/VZV endotheliitis

Non-granulomatous (fine)

KP Morphology: Small, round, white
Distribution: Arlt's triangle (inferior cornea)
Example Conditions: HLA-B27, idiopathic AAU

Granulomatous (mutton-fat)

KP Morphology: Large, greasy, yellow-brown
Distribution: Arlt's triangle
Example Conditions: Sarcoidosis, TB, VKH

Stellate (FHI-type)

KP Morphology: Small, stellate/round
Distribution: Diffuse — entire endothelium
Example Conditions: Fuchs heterochromic iridocyclitis

Coin-shaped

KP Morphology: Medium, round, flat
Distribution: Central/paracentral
Example Conditions: HSV/VZV endotheliitis

Self-Assessment (5)

MCQ

A 32-year-old woman is found to have mild anterior chamber cells, diffuse small stellate KPs over the entire corneal endothelium, and iris heterochromia on routine examination. She has no posterior synechiae. What is the most likely diagnosis?

MCQ

Which viral pathogen is most strongly implicated in the aetiology of Fuchs heterochromic iridocyclitis?

MCQ

A patient with FHI develops refractory elevated IOP despite maximum medical therapy. What is the most appropriate surgical intervention?

MCQ

What is the Amsler sign in the context of Fuchs heterochromic iridocyclitis?

MCQ

Which of the following features, if present, should make you reconsider the diagnosis of Fuchs heterochromic iridocyclitis?

References

AAO Preferred Practice Pattern: Uveitis — Non-Infectious (2019)
Nussenblatt RB, Whitcup SM. Uveitis: Fundamentals and Clinical Practice, 4th Edition. Mosby, 2010.
Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol. 2004;138(1):46-54.
La Hey E, de Jong PT, Kijlstra A. Fuchs heterochromic cyclitis: review of the literature on the pathogenetic mechanisms. Br J Ophthalmol. 1994;78(4):307-312.
Mohamed Q, Zamir E. Update on Fuchs' uveitis syndrome. Curr Opin Ophthalmol. 2005;16(6):356-363.
Kanski JJ, Bowling B. Clinical Ophthalmology: A Systematic Approach, 9th Edition. Elsevier, 2020.

Topic complete

Continue to another topic when you are ready.

Previous topic← Endophthalmitis Next topicHLA-B27 anterior uveitis